BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 15166066)

  • 1. Psychological impact of human papillomavirus testing in women with borderline or mildly dyskaryotic cervical smear test results: cross sectional questionnaire study.
    Maissi E; Marteau TM; Hankins M; Moss S; Legood R; Gray A
    BMJ; 2004 May; 328(7451):1293. PubMed ID: 15166066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The psychological impact of human papillomavirus testing in women with borderline or mildly dyskaryotic cervical smear test results: 6-month follow-up.
    Maissi E; Marteau TM; Hankins M; Moss S; Legood R; Gray A
    Br J Cancer; 2005 Mar; 92(6):990-4. PubMed ID: 15785734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testing positive for human papillomavirus in routine cervical screening: examination of psychosocial impact.
    McCaffery K; Waller J; Forrest S; Cadman L; Szarewski A; Wardle J
    BJOG; 2004 Dec; 111(12):1437-43. PubMed ID: 15663132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychosocial outcomes of three triage methods for the management of borderline abnormal cervical smears: an open randomised trial.
    McCaffery KJ; Irwig L; Turner R; Chan SF; Macaskill P; Lewicka M; Clarke J; Weisberg E; Barratt A
    BMJ; 2010 Feb; 340():b4491. PubMed ID: 20179125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychological burden of testing positive for high-risk human papillomavirus on women with atypical cervical cytology: a prospective study.
    Kwan TT; Cheung AN; Lo SS; Lee PW; Tam KF; Chan KK; Ngan HY
    Acta Obstet Gynecol Scand; 2011 May; 90(5):445-51. PubMed ID: 21306349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anxiety and distress following receipt of results from routine HPV primary testing in cervical screening: The psychological impact of primary screening (PIPS) study.
    McBride E; Marlow LAV; Forster AS; Ridout D; Kitchener H; Patnick J; Waller J
    Int J Cancer; 2020 Apr; 146(8):2113-2121. PubMed ID: 31251820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lifetime effects, costs, and cost effectiveness of testing for human papillomavirus to manage low grade cytological abnormalities: results of the NHS pilot studies.
    Legood R; Gray A; Wolstenholme J; Moss S
    BMJ; 2006 Jan; 332(7533):79-85. PubMed ID: 16399769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring reasons for variations in anxiety after testing positive for human papillomavirus with normal cytology: a comparative qualitative study.
    McBride E; Marlow LAV; Bennett KF; Stearns S; Waller J
    Psychooncology; 2021 Jan; 30(1):84-92. PubMed ID: 32909308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychological costs of inadequate cervical smear test results.
    French DP; Maissi E; Marteau TM
    Br J Cancer; 2004 Nov; 91(11):1887-92. PubMed ID: 15534608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mildly abnormal cervical smear: patient anxiety and choice of management.
    Jones MH; Singer A; Jenkins D
    J R Soc Med; 1996 May; 89(5):257-60. PubMed ID: 8778432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychosocial impact of inclusion of HPV test on the management of women with atypical squamous cells of undetermined significance: a study within a randomised pragmatic trial in a middle-income country.
    Garcés-Palacio IC; Sanchez GI; Baena Zapata A; Córdoba Sánchez V; Urrea Cosme Y; Rodríguez Zabala D; Ruiz Osorio MA
    Psychol Health; 2020 Jun; 35(6):750-769. PubMed ID: 31625399
    [No Abstract]   [Full Text] [Related]  

  • 12. Swedish women's awareness of human papillomavirus, and health-related quality of life, anxiety, and depression after a notification of an abnormal Pap smear result: a cross-sectional study.
    Rask M; Swahnberg K; Oscarsson M
    Eur J Cancer Prev; 2019 Mar; 28(2):96-101. PubMed ID: 29406336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 'I don't care whether it's HPV or ABC, I just want to know if I have cancer.' Factors influencing women's emotional responses to undergoing human papillomavirus testing in routine management in cervical screening: a qualitative study.
    O'Connor M; Costello L; Murphy J; Prendiville W; Martin CM; O'Leary JJ; Sharp L;
    BJOG; 2014 Oct; 121(11):1421-9. PubMed ID: 24690225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevalence of human papillomavirus infection in Slovenian women with repeated Pap II smears].
    Salimović-Besić I; Bokal EV; Poljak M; Kocjan B
    Med Arh; 2005; 59(1):47-51. PubMed ID: 15822686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychological Impact of Primary Screening (PIPS) for HPV: a protocol for a cross-sectional evaluation within the NHS cervical screening programme.
    McBride E; Marlow L; Forster AS; Moss S; Myles J; Kitchener H; Patnick J; Waller J
    BMJ Open; 2016 Dec; 6(12):e014356. PubMed ID: 28011816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomised controlled trial of cytological surveillance versus patient choice between surveillance and colposcopy in managing mildly abnormal cervical smears.
    Kitchener HC; Burns S; Nelson L; Myers AJ; Fletcher I; Desai M; Dunn G; Maguire P
    BJOG; 2004 Jan; 111(1):63-70. PubMed ID: 14687054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triage using HPV-testing in persistent borderline and mildly dyskaryotic smears: proposal for new guidelines.
    Bais AG; Rebolj M; Snijders PJ; de Schipper FA; van der Meulen DA; Verheijen RH; Voorhorst F; van Ballegooijen M; Meijer CJ; Helmerhorst TJ
    Int J Cancer; 2005 Aug; 116(1):122-9. PubMed ID: 15751045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mildly dyskaryotic smear results: does it matter what women know?
    Somerset M; Baxter K; Wilkinson C; Peters TJ
    Fam Pract; 1998 Dec; 15(6):537-42. PubMed ID: 10078794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychosexual distress following routine primary human papillomavirus testing: a longitudinal evaluation within the English Cervical Screening Programme.
    Bennett KF; Waller J; McBride E; Forster AS; Di Gessa G; Kitchener H; Marlow L
    BJOG; 2021 Mar; 128(4):745-754. PubMed ID: 32783300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus type-specific 18-month risk of high-grade cervical intraepithelial neoplasia in women with a normal or borderline/mildly dyskaryotic smear.
    Berkhof J; Bulkmans NW; Bleeker MC; Bulk S; Snijders PJ; Voorhorst FJ; Meijer CJ
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1268-73. PubMed ID: 16835322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.